Palo Alto Investors »

Denali Therapeutics shares owned by Palo Alto Investors

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.9M 408k 14.52
2025-06-30 $3.4M 240k 13.99